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Abstract: Home blood pressure monitoring (HBPM) is a convenient way to assess outof-office blood pressure control and is recommended by numerous international
guidelines to aid clinicians in the diagnosis and management of essential hypertension.
Although available guidelines recommend the use of HBPM in patients receiving
antihypertensive medication, their specific recommendations regarding
optimal monitoring schedule, duration, and clinician interpretation of home blood
pressure readings may differ among guidelines. The purpose of this article is to review
available international hypertension guideline recommendations related to the use of
HBPM to improve hypertension control among patients receiving antihypertensive
therapy. We also briefly highlight clinical trials that have shown improved blood pressure
control using HBPM to intensify antihypertensive therapy and provide a practical guide
for implementing HBPM to improve hypertension control. Eleven international guidelines
were identified and reviewed. In total, recommendations relating to which HBPM to use,
number of measurements per day, and how to interpret home blood pressure values
were largely in agreement among available guidelines. Clinicians recommending HBPM
to their patients with hypertension should utilize a standardized HBPM protocol, based
on available guideline recommendations.
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Introduction
Hypertension, or elevated blood pressure (BP), is a leading modifiable risk factor for

3

cardiovascular disease, stroke, and kidney disease.1 In the United States (US), the prevalence

4

of hypertension varies from approximately 32% to 45% of adults, depending on BP thresholds

5

used to define elevated BP.2 Despite effective and affordable antihypertensive medications, an

6

estimated 28.7% of patients treated for hypertension have uncontrolled BP.2 Unfortunately,

7

recent data suggest that BP control rates are declining among US adults with hypertension,

8

while cardiovascular deaths related to hypertension are increasing.3,4

9
10

Historically, decisions to initiate or intensify antihypertensive therapy have been based

11

on office-measured BP values taken at clinician's office. Multiple factors can lead to inaccurate

12

office-measured BP readings, including improper patient position, inappropriate BP

13

measurement technique, and patient anxiety attributed to the healthcare setting.5 Given the

14

potential for inaccurate office-measured BP and increased availability of home BP monitors,

15

recent guidelines have advocated for the use of out-of-office BP monitoring to confirm the

16

diagnosis of hypertension and to monitor treatment response in those taking antihypertensive

17

therapy.5–7 Current options for out-of-office BP measurement include 24-hour ambulatory BP

18

monitoring and home BP monitoring (HBPM). HBPM has several advantages over office-

19

measured BP, including a more reliable assessment of patients’ BP in their natural setting,

20

multiple readings over several days, and has been shown to be more closely related to risks of

21

developing hypertension end-organ damage and cardiovascular events compared to office-

22

measured BP.8 Current hypertension guidelines recommend HBPM to confirm the diagnosis of

23

hypertension, assess for white-coat or masked hypertension in patients not currently taking

24

antihypertensive therapy, and evaluate BP control and medication adherence in those receiving

25

antihypertensive treatment.9

26
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27

Use of HBPM in clinical practice appears to be increasing as clinicians are increasingly

28

recommending HBPM to their patients with elevated BP. In one survey, 96.8% of primary care

29

clinicians reported using patient self-monitored BP readings and 98.5% reported making

30

changes to medications based on patients’ home BP readings.9 Likewise, patients are open to

31

HBPM also. A recent survey of patients with hypertension reported that 30.1% stated their

32

physician had recommended HBPM.10 Among those recommended to use HBPM, 82%

33

reportedly complied.10 While multiple international hypertension guidelines recommend HBPM

34

for patients treated with antihypertensive medications,5,7,11,12 standardized clinical HBPM

35

protocols for educating patients on appropriate use or recommended monitoring schedules are

36

lacking. In a survey of primary care providers, nearly 97% of clinicians reported using HBPM in

37

their patients; however, 99.5% of clinicians reported that HBPM patient education was done by

38

a team member and not the clinician.9 Another survey examined the proportion of clinics with

39

appropriate procedures for recommending HBPM based on current guidelines for out-of-office

40

BP monitoring. Among the surveyed clinics, 48.8% utilized a non-clinician staff to provide HBPM

41

training to patients, while only 27.6% reported a standardized policy for training patients on

42

appropriate HBPM use.9

43
44

Given the increasing use of HBPM to manage hypertension, a consistent protocol for

45

assessing and interpreting home BP readings is needed to ensure clinicians are following best

46

practices. In this review, we compare recommendations from available international

47

hypertension guidelines on clinical use of HBPM and interpreting home BP values to adjust

48

antihypertensive medication. Additionally, we review monitoring schedules used in several

49

clinical trials supporting HBPM to improve hypertension control, as well as provide a practical

50

guide for implementing HBPM in clinical practice to improve BP control rates.

51
52
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53

Recommendations for Home Blood Pressure Monitoring

54

A search for international hypertension guidelines providing specific recommendations

55

for use of HBPM in patients treated for hypertension was conducted using PubMed. Guideline

56

statements and consensus documents published from major hypertension management

57

organizations within the last 10 years, and providing specific recommendations for HBPM and

58

interpretation were included. Although the terms, “self-measured BP monitoring” and “HBPM”

59

may seem interchangeable, HBPM specifically refers to BP measurement in ones’ home, but

60

may be performed by someone other than the patient.5 Self-measured BP monitoring refers to

61

BP measured by the individual, although it may occur outside of their home.9 For the remainder

62

of this article, the term HBPM will be used as it is the term commonly used in available

63

guidelines. A total of eleven international guidelines were identified and are summarized in

64

Table 1.

65
66
67

Recommendations for Home BP Monitoring Devices
Reviewed guidelines favor the use of automated, oscillometric HBPM devices over the

68

use of manual devices. Automated monitors with upper-arm cuffs assessing pressure of the

69

brachial artery are consistently preferred over wrist or finger devices (Figure 1) when

70

appropriate cuff sizes are available.5,6,8,11–17 Wrist monitors are less reliable in comparison to

71

upper arm cuffs due to incorrect positioning in relation to the heart and measurement of BP in

72

both the radial and ulnar arteries, but may be considered in patients who are unable to obtain an

73

appropriately sized upper-arm cuff.8 All eleven reviewed guidelines recommend using a

74

validated HBPM for assessing BP control, yet only five cite resources for choosing a validated

75

monitor6,8,14–16 (Table 2). Home BP monitors should also be routinely calibrated, and guidelines

76

recommend clinicians compare office-measured BP against patients’ home device before

77

initiation HBPM and periodically thereafter.5,12–15,17 Patients should receive education regarding

5

78

appropriate HBPM use, and clinicians should assess patients’ technique before initiation HBPM,

79

and periodically thereafter.5,12,14,15

80
81
82

Recommendations for Optimal BP Monitoring Schedule
Available guidelines provide specific instructions for the number of BP measurements

83

per day and frequency of monitoring for appropriate assessment. All guidelines agree upon

84

testing BP twice daily (in the morning and evening), with two consecutive measurements taken

85

1-2 minutes apart each time. Prior to each measurement, patients should be resting for at least

86

5-minutes and positioned correctly (Figure 2). Reviewed guidelines offer varying

87

recommendations regarding conditions prior to taking BP measurements, such as before or

88

after meals and time since waking in the morning, yet most agree that morning BP

89

measurements should be taken after emptying one’s bladder and before typical morning

90

activities (caffeine, exercise, smoking). Four guidelines recommend assessing BP before the

91

morning meal,11–13,16 and nine guidelines specify morning BP readings be taken before

92

administering antihypertensive medications.5,6,8,11–13,15–17 Recommendations for evening BP

93

readings are less consistent regarding timing in relation to meals. Three guidelines recommend

94

measuring evening BP before the evening meal,8,16,17 two guidelines recommend measuring

95

after the evening meal,11,15 and three guidelines call for measuring BP before bed.5,12,13

96

Considering some patients may be taking antihypertensive medications more than once per

97

day, two guidelines specify that evening BP measurements be taken before administering

98

evening antihypertensive medications.11,16

99

The duration of HBPM assessment varies slightly between the reviewed guidelines;

100

however, it is acknowledged that longer periods of continuous assessment provide superior

101

data for managing hypertension. Consecutive measurements taken over a 3-day and ideally 7-

6

102

day period are recommended to assess BP control. Excluding BP measurements taken the first-

103

day is recommended by most guidelines, given expected higher values on the first day of

104

evaluation. Once BP control is achieved, recommendations for continued HBPM measurement

105

are mixed, ranging from weekly to biannually.6,8,11,13–16 Time frames to reassess control of

106

hypertension with HBPM should be determined based on patient-specific factors such as

107

medication adherence, cardiovascular risk, comorbid conditions, age, and potential for labile

108

BP. Providers should be mindful of “monitoring-fatigue” when patients are asked to continuously

109

monitor home BP despite controlled BP.

110
111

Evaluating Home BP to Guide Treatment Intensification

112

In patients treated with antihypertensive medications, assessing BP control with HBPM

113

requires patients to measure BP over a minimum 3-day period, preferably a consecutive 7-day

114

period, beginning 1-week prior to their next clinic visit. To assess BP control, guidelines

115

recommend averaging all systolic and diastolic values taken during the 3 to 7-day measurement

116

period (excluding readings on day 1). Two guidelines recommend averaging morning and

117

evening values separately.12,13 If the calculated average home BP is 135/85 mmHg or higher,

118

equivalent to an office-measured BP of 140/90 mmHg, guidelines unanimously recommend

119

intensifying antihypertensive therapy. Specific home BP goals are not recommended by most

120

guidelines, although two guidelines offer specific home BP goals. The HOPE Asia Network

121

recommends home BP goal of <135/85 mmHg for patients under 80 years, home BP of <145/85

122

mmHg for patients above age 80, and a systolic BP (SBP) goal of <125 mmHg for patients at

123

increased cardiovascular risk, such as those with diabetes, chronic kidney disease, or

124

cardiovascular disease.12 The 2020 Taiwan Hypertension Society considers home BP to be

125

“well-controlled” if both the morning and evening average BP values are <135/85 mmHg.13

7

126

Further, patients with hypertension-related organ damage are recommended to achieve a home

127

BP of <130/80 mmHg.13 Time frames for reassessing home BP following adjustment of

128

antihypertensive medications is provided in two guidelines. Recommendations from Australian

129

guidelines16 call for reassessing home BP values approximately 4-weeks after medication

130

adjustment, while guidelines from Taiwan13 recommend re-evaluating home BP control after 2

131

weeks.

132
133
134

Home Blood Pressure Monitoring Schedules from Clinical Trials
Multiple studies have evaluated changes in BP when HBPM is combined with additional

135

management compared to usual care. A brief review of several of those trials, including how

136

HBPM data was used to guide hypertension treatment, is described below.

137
138

A randomized trial compared HBPM with pharmacist management to usual care among

139

patients with uncontrolled BP.13 Patients randomized to the HBPM group received a HBPM

140

home and advised to check home BP 3-times per week and upload their results weekly to a

141

web-based application which calculated weekly averages. These results were reviewed by

142

clinical pharmacists, who contacted patients to assess medication adherence and if needed,

143

intensify antihypertensive therapy. The proportion of patients with controlled BP at 6-months

144

was greater in the HBPM group compared to usual care (Table 3). Additionally, patient reported

145

satisfaction with hypertension care was also greater in the HBPM group versus usual care.

146
147

A randomized cluster trial evaluated hypertension control rates among patients receiving

148

HBPM with pharmacist-management compared to usual care over an 18-month period.18

149

Patients in the HBPM cohort were asked to submit at least six BP readings per week, preferably

150

3 readings taken in the morning and 3 readings in the evening. Pharmacist follow-up with HBPM

8

151

patients occurred every 2 weeks until their home BP was controlled. Instead of average BP

152

values to determine control, pharmacists evaluated the proportion of controlled home BP

153

readings, where treatment intensification would be recommended if less than 75% of BP

154

readings were controlled. HBPM and follow-up was continued for 12 months, then patients

155

returned to usual care for hypertension management. Hypertension control rates were

156

significantly higher among the HBPM cohort compared to usual care even at 18-months, 6-

157

months after the HBPM intervention had ended.18 An extension of this trial found no significant

158

difference in systolic or diastolic BP (DBP) at 54 months between HBPM and usual care groups,

159

concluding that maintaining long-term BP control requires continued monitoring and resumption

160

of HBPM intervention if BP increases.19

161
162

Home BP monitoring with additional management appears to improve hypertension

163

control compared to usual care, but whether HBPM alone results in improved hypertension

164

control was assessed in a randomized trial by Green et al.20 Patients with uncontrolled

165

hypertension despite antihypertensive therapy were eligible for one of three interventions: usual

166

care, HBPM with results reported to their primary care physician (HBPM-PCP), or HBPM with

167

pharmacist-management (HBPM-Pharmacist). Patients in both HBPM groups received training

168

on appropriate use of a validated BP meter, and instructions to measure their BP at least twice

169

per week, with two measurements each time. Home BP values were reported to PCPs or

170

clinical pharmacists via a secure web-based messaging system. Patients randomized to the

171

HBPM-Pharmacist group received follow-up management from clinical pharmacists every two

172

weeks until their BP was controlled. The HBPM-Pharmacist group resulted in the largest

173

proportion of patients with controlled in-clinic BP (defined as <140/90 mmHg) at 12-months.20

174
175
176
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177

Discussion

178

Among the international guidelines for HBPM, there is overwhelmingly agreement

179

among recommendations for using HBPM to assess and manage hypertension. Available

180

guidelines provide similar recommendations for choosing a validated monitor and patient-

181

preparation prior to BP measurements (empty bladder, resting for at least 5 minutes, using a

182

monitor device with an arm cuff, and placing the BP cuff on bare skin).5,8,11,12,16 Perhaps key to

183

using HBPM is ensuring patients use a validated BP monitor and education on appropriate use

184

and monitoring schedule. Specific resources where patients and clinicians can view validated

185

BP monitors are provided in five guidelines.6,8,14–16 . Recommended schedules to evaluate BP

186

control in patients receiving antihypertensive medication were highly concordant in endorsing

187

two measurements per day, in the morning before antihypertensive medication and in the

188

evening, with 2 readings taken at least 1-minute apart each time. Additionally, at least 3-days of

189

HBPM data and optimally 7-days is sufficient to assess BP control, with average home BP

190

values 135/85 mmHg or higher indicating uncontrolled hypertension. Seven guidelines

191

recommend omitting first-day readings due to concerns that these readings will likely be higher

192

than subsequent day readings, and may increase the 7-day average.6,8,11–14,16,17

193
194

Recommendations with the greatest disagreement were related to guidance on timing of

195

evening BP measurements. Among the guidelines reviewed, three offered no recommendation

196

regarding evening BP measurements with regard to meals,6,7,14 three recommend measuring

197

before the evening meal,8,16,17 three recommend measuring before bedtime,5,12,13 and one

198

guideline specifies measuring evening 2-hours after the evening meal.11 Postprandial

199

hypotension, defined as a reduction in SBP of 20 mmHg or more within 2 hours of a meal, is

200

common in elderly patients and may or may not be symptomatic.22 To minimize the postprandial

201

hypotension, which may produce artificially low evening BP values, evening BP should be

202

measured before meals, or at least 2-hours after. When interpreting home BP readings, the

10

203

average SBP and DBP should be used to assess BP control, rather than assessing the

204

proportion of days controlled. Consistent among all included guidelines was an average home

205

BP of 135/85 mmHg or higher corresponded to an office-measured BP of 140/90 mmHg or

206

more, and should prompt treatment intensification. While most guidelines (6 out of 11)

207

recommend routine calibration of home BP monitors against office-BP, specific details regarding

208

when and how often this should be done are lacking. At a minimum, annual evaluation of

209

patients’ HBPM technique and the accuracy of their HBPM seems appropriate.

210
211

Evidence supporting use of HBPM with additional management utilized a variety of

212

HBPM schedules, none of which follow current recommendations. Although trials used different

213

HBPM schedules, each used the same home BP threshold of ≥135/85 mmHg to guide

214

antihypertensive intensification, thus the specific monitoring schedule may be less relevant than

215

treatment intensification when average home BP readings are elevated. A 2017 meta-analysis

216

evaluated changes in BP and control rates with HBPM compared to usual care, but categorized

217

HBPM use by levels of additional co-interventions.23 Twenty trials with individual patient data

218

were included, and stratified by intensity of co-intervention. Studies which used HBPM alone

219

showed modest reductions in SBP and DBP at 12 months, and no significant improvement in

220

BP control rates. However, studies which combined HBPM with more intense interventions,

221

such as patient education and medication management, were associated with significant

222

decreases in SBP (-6.1 mmHg) and DBP (-2.3 mmHg).23 Additionally, patients who received

223

HBPM with more intensive co-interventions were 40-50% more likely to achieve BP control

224

compared to usual care.23 Thus, available data support greater reductions in SBP and DBP, as

225

well as improved BP control rates, when HBPM is used along with additional patient education

226

or medication management strategies.

227
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228

Best practices related to HBPM for hypertension management should include

229

standardized patient-education material, including written instructions clearly explaining proper

230

measurement and monitoring schedule for obtaining home BP values. Additionally, a

231

standardized approach for assessing BP control using home-monitored BP values according to

232

current guidelines should be encouraged among all clinicians. Given that some clinicians may

233

not be aware of recommendations for HBPM or evaluating home BP values, a recent statement

234

on the use of self-measured BP monitoring from the American Heart Association and American

235

Medical Association (AHA/AMA) has called for additional education for health care professionals

236

to increase their knowledge and skills related to self-measured BP monitoring and ensure core

237

competencies of HBPM in clinical practice.9 All clinicians involved in treating hypertension

238

should be aware of the recommended monitoring schedule, as well as correctly interpreting

239

home BP values to improve hypertension control rates.

240
241
242

Conclusion
Hypertension control rates remain unsatisfactorily low among patients treated with

243

effective antihypertensive therapy. HBPM is recommended by multiple international

244

hypertension guidelines as an effective way to assess BP control in patients treated with

245

antihypertensive medications. Clinicians who recommend HBPM should educate patients on

246

proper home BP measurement techniques, as well as recommend validated automatic monitors

247

which measure BP from the upper arm. Available guidelines largely recommend a standardized

248

HBPM schedule, including measuring BP twice per day for seven days, should be used to

249

assess BP control. Averaged home BP values should be used to evaluate BP control, with

250

prompt antihypertensive adjustment recommended if average home BP readings are above

251

135/85 mmHg, and close follow-up monitoring thereafter to ensure continued BP control.

252
253
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Pre-monitoring patient
education
•

Choose a validated, upper-arm
home BP device, with
appropriate size cuff

•

Demonstrate appropriate
measurement technique;
ensure patient can replicate
appropriate technique

•

Prepare for BP measurement
•
Empty bladder
•
Rest for ≥5 minutes
quietly
•
Sit up right, with legs
uncrossed and flat on
floor
•
Place cuff on bare arm
and rest arm on flat
surface (Figure 1)
•
Avoid exercise, caffeine,
or tobacco at least 30
minutes
•
Do not talk during rest
or BP measurements

Clinician Evaluation

Home BP Measurement
•

Beginning 1-week prior to the clinician
visit, measure BP twice per day
•
In the morning and evening
•
Before taking BP medications
•
Before meals

•

•
•
•

•

Take 2 readings each time, separated by
1-2 minutes
Record the time, date, and BP results
for at least 3 days in a row, but
preferrable 7 days in a row

•

Review patient’s home BP readings
•
Minimum of 3-days (12 readings); preferably 7days (28 BP readings)
•
Consider discarding readings from the first day of
measurement
Assess patient’s adherence to lifestyle modifications and
medication(s)
Average systolic and diastolic readings (discard first-day
values may be appropriate)

Bring results and home BP monitor to
clinician appointment

•
•

•
•

If average home BP ≥135/85 mm Hg:
Re-enforce adherence to lifestyle modifications and medication(s)
Intensify antihypertensive treatment to achieve average BP <135/85 mm Hg

Follow-up in 2-4 weeks:
Evaluate last 3-7 days worth of home BP readings and adherence as recommended above
Once home BP controlled, advise patient to monitor 1-2 days per week every 3-6 months

•
•

Annually:
Evaluate patient’s BP measurement technique
Validate patient’s HBPM for accuracy

Figure 1: Correct position of arm with home blood pressure monitor
Figure 2: Recommended clinical approach to implementing home blood pressure monitoring to
improve hypertension control.

Guideline or
Consensus document

2021 European
Society of
Hypertension8

2020 Taiwan
Hypertension
Society13

Frequency of
readings

2 measurements
per occasion taken
1 minute apart

≥2 readings 1
minute apart

Time of day

Morning: before
medications and
food
Evening: before
medications and
food

Morning: within 1
hour of awakening,
before food and
medications
Evening: within 1
hour of bedtime

Duration of
assessment
Uncontrolled:
7 days
recommended with
minimum of 3 days
(12 readings) before
clinic visit
Controlled:
Two measurements
1-2 per week or per
month

Uncontrolled:
4-7 consecutive
days once a month
or beginning 2weeks after
adjusting
medication
Controlled:
Perform 722
principle at least
every 3 months

Evaluation

Notes

Average HBPM values,
excluding first-day
readings

-Upper arm oscillometric
device with automated
measurement storage and
averaging features
preferred
with semi-automated or
automated devices

BP ≥135/85 mmHg
suggests uncontrolled
BP

Average AM and
evening values
separately, excluding
first-day readings
BP<135/85 mmHg for
AM and evening
considered controlled
For patients with
hypertension-mediated
organ damage,
BP<130/80 mmHg
considered controlled

-Validated wrist devices by
be used in those with very
large arms
-Upper arm preferred
location with validated,
oscillometric device
-defines a “722” principle,
relating to every 7 days,
measure BP twice a day,
with 2 readings each time
-in well-controlled patients,
one duplicate
measurement once per
week may be an
alternative to performing
the 722 principle every 3
months.

2020 International
Society of
Hypertension6

2020 Hypertension
Canada11

2 successive
measurements 1
min apart

2 duplicate
measurements
conducted in series

Morning: before
medications and
evening

Morning: before
breakfast and before
medication
Evening: 2 hours
after dinner and
before medication

Uncontrolled:
3-7 days
Controlled:
1-2 measurements
per week or month

Average HBPM values,
excluding first-day
readings
BP ≥135/85 mmHg
suggests uncontrolled
BP

Uncontrolled:
7 days

Average HBPM values,
excluding first-day
readings

Controlled:
1-week HBPM
every 3 months

BP ≥135/85 mmHg
suggests uncontrolled
BP

-Upper arm preferred
location with validated,
oscillometric device

-Upper arm preferred
location with validated
oscillometric device
-Non-dominant arm should
be used unless SBP
between arms is >10 mm
Hg in which arm with
highest value is used
-Wrist devices can be
used for patients with
large arm circumference

AHA 2019 Scientific
Statement5

2 readings at least 1
minute apart

Morning: before
medication
Evening: before bed

Uncontrolled:
> 7 consecutive
days with minimum
of 3 days before
next provider
appointment

Average HBPM values,
consecutive day
monitoring ideal
If 1st day readings
discarded, evaluate
days 4-8
BP ≥135/85 mmHg
suggests uncontrolled
BP

2019 Chinese
Hypertension
League15

2019 Latin American
Society of
Hypertension17

2-3 consecutive
measurements 1
minute apart after 5
minutes of rest

2 successive
measurements at
each check taken 12 minutes apart

Morning: 1 hour after
getting up, before
breakfast and
medication
Evening: after meal

Morning: before
medication
Evening: before
dinner

Uncontrolled:
Successively for 5-7
days
Controlled:
Minimum of 1 day
per week

Minimum of 3 days
and preferred 7
days before clinic
visit

Average HBPM values

-If first day of readings is
excluded, 4-8 days of
average HBPM values are
required
-Upper arm preferred
location with validated,
oscillometric device.
-Device should
automatically store all
readings, print log of
stored readings, and
electronically send data to
provider
- Upper-arm automated
oscillometric electronic,
validated devices per
standardized protocol

BP ≥135/85 mmHg
suggests uncontrolled
BP

-Finger and wrist devices
not recommended

Average HBPM values,
excluding first-day
readings

-Upper arm automated
device that has been
validated according to
internationally accepted
validated protocols

BP ≥135/85 mmHg
suggests uncontrolled
BP

-Recommended that
normotensive patients
assess HBPM yearly

-Wrist cuffs not
recommended except in

the case of severe obesity
with very large arm size
-Upper arm preferred
location with validated,
brachial oscillometric
device

2017 HOPE Asia
network12

2 successive
measurements

Morning: within 1hour of waking,
before medication
and food

Uncontrolled:
Minimum of 3 days
and preferred 7days

Evening: before
bedtime

2018 ESC/ESH
Hypertension
Guideline7

2 successive
measurements 1-2
minutes apart

Morning and
evening

Average HBPM values,
excluding first-day
readings
Calculate average for
morning and evening
values separately
BP ≥135/85 mmHg
suggests uncontrolled
BP

Uncontrolled:
Minimum of 3
consecutive days
with preferred 6- 7
consecutive days

-Alternative monitors
acceptable when brachial
device is not feasible.
Requires device
calibration every 6-12
months
-Assess morning variability
with standard deviation of
morning values over
minimum of 3 consecutive
days
-Assess morning surge by
subtracting evening SBP
from morning SBP
-Assess morning/evening
difference by subtracting
sleep SBP from morning
SBP

Average HBPM values,
excluding first-day
readings

-Upper arm preferred
location with validated
oscillometric device

Morning and
evening at same
time each day and
before medication,
food, and vigorous
exercise
2016 Royal
Australian College16

British Hypertension
Society home blood
pressure monitoring
protocol14

2 successive
measurements at
least 1 minute apart

2 consecutive
measurements 1
minute apart

Acceptable to
assess in late
morning (especially
if on
antihypertensive
medications) to
catch lowest BP
value

Morning: between 6
AM and 12 PM
Evening: between 6
PM and 12 AM
before medication

Uncontrolled:
7-day period before
clinic visit; minimum
5 days
Medication
adjustment:
7-day HBPM 4
weeks after
medication
adjustment
Controlled:
Conduct HBPM at
regular intervals
(e.g., every 6
months)
Uncontrolled:
4-7 days before
clinic appointment
Controlled:
1-2X per week
Or 4-7 days
consecutively every
4-6 months

BP ≥135/85 mmHg
suggests uncontrolled
BP

Average HBPM values,
excluding first-day
readings
BP ≥135/85 mmHg
suggests uncontrolled
BP

Average HBPM values,
excluding first-day
readings
BP ≥135/85 mmHg
suggests uncontrolled
BP

-Upper arm preferred
location with automated,
validated device.
-Device with memory
storage preferred
-Validated wrist device
acceptable if large arm
circumference

-Upper arm preferred
location with automatic,
validated, oscillometric
device
-Arm with higher systolic
reading should be used for
assessment

Abbreviations: AHA= American Heart Association; BP=blood pressure; ESC/ESH=European Society of Cardiology/European Society
of Hypertension; HBPM=home blood pressure monitoring.
Table I: Recommendations for home blood pressure monitoring from International Hypertension Guidelines

Resource listing validated
home blood pressure
monitors
www.stridebp.org
www.bihsoc.org
www.validatebp.org

Recommended by International Guideline
2019 Chinese Hypertension League
2020 International Society of Hypertension
2021 European Society of Hypertension
2016 Royal Australian College of General Practitioners
British and Irish Hypertension Society
Recommended for United States population

Table 2: Available resources for choosing validated home blood pressure monitors.

Study

Population

Green et
al.20

Patients with
uncontrolled
office-BP while
receiving
antihypertensive
therapy

Intervention

Usual care
(n=258)
HBPM values
reported to
PCP [HBPMPCP] (n=259)
HBPM with
pharmacist
management
[HBPM-Pharm]
(n=261)

Recommended
home BP
monitoring
schedule

At least 2 readings
per week; 2
measurements
each time
Follow-up with
pharmacist
management
occurred every 2
weeks

Results

•
•

•

•
•
•

Change in SBP
(mmHg) at
12-months:
Usual care: -5.3
HBPM to PCP: -8.2
(P<0.05 for usual
care versus HBPM
to PCP groups)
HBPM-Pharm: -14.2
(p<0.001 for HBPMPCP versus HBPMPharm)
Change in DBP
(mmHg) at
12-months:
Usual care: -3.5
HBPM-PCP: -4.4
HBPM-Pharm: -7.0
(p<0.001 for HBPMPCP vs HBPMPharm with)

Proportion of patients
with controlled BP at
12-months:
• Usual care: 31%
• HBPM-PCP: 36%
• HBPM-Pharm: 56%
(p<0.001 for HBPMPCP vs HBPMPharm)
Magid et
al.21

Patients from 10
Kaiser
Permanente
clinics with
uncontrolled BP
while taking ≤ 3

Usual Care
(n=173)
HBPM with
pharmacist

At least 3 BP
measurements per
week, uploaded
weekly

Proportion of patients
who met BP goal at 6months:
• Usual Care: 35.4%
• HBPM: 54.1%
(p>0.001)

antihypertensive management
agents
(n=175)

Weekly average BP
reviewed by clinical
pharmacists
•
•

Reduction in BP
(mmHg) in HBPM
group vs usual
care at 6-months:
SBP: -12.4
DBP: -5.7

Percentage of patients
reporting very or
completely satisfied
with hypertension
care:
• Usual Care: 42%
• HBPM: 58%
(p<0.001)
Margolis
et al.18

Patients with
uncontrolled BP
while receiving
antihypertensive
therapy

Usual Care for
12 months
(n=222)
HBPM with
pharmacist
intervention for
12 months
(n=228)

At least 6 BP
readings weekly (3
from morning; 3
from evening)
Follow-up with
pharmacist
management
occurred every 2
weeks

6-month BP control
(HBPM vs usual care):
• 71.8% vs 45.2%
(p<0.0001)
12-month BP control
(HBPM vs usual care):
• 71.2% vs 52.8%
(p<0.005)
18-month BP control
(HBPM vs usual care):
• 71.8% vs 57.1%
(p<0.003)
Reduction in SBP at
12-months
(HBPM vs usual care):
• -9.7 mmHg
(p<0.001)
Reduction in DBP at
12-months
(HBPM vs usual care):
• -5.1 mmHg
(p<0.001)

Abbreviations: BP= blood pressure; DBP= diastolic blood pressure; HBPM=home blood
pressure monitoring; PCP= primary care physician; SBP= systolic blood pressure
Table 3: Home blood pressure monitoring schedules and outcomes from select clinical trials

